维普期刊资源整合服务平台（V6.5）

128篇 您的检索式：作者名="Supko"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer 显示文摘	Goffin JR Anderson IC Supko JG	2005	Clin Cancer Res2005，11，：	1
2	Phase Ⅱ and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy显示文摘	Garcia-Carbonero R Supko JG Maki RG	2005	J Clin Oncol2005，23，24：	1
3	Phase Ⅰ clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily显示文摘	Eder J P Jr Supko J G Clark J W	2002	J Clin Oncol2002，20，18：	1
4	Preelinical pharmacologic evaluation of geldanarnycin as an antiturnor agent显示文摘	Supko J G Hickman R L Grever M R	1995	Cancer Chemother Pharmacol1995，36，4：	1
5	A phase Ⅱ study of weekly paclitaxel in elderly patients with advanced non-small cell lung cancer显示文摘	Fidias P Supko JG Martins R	2001	Clin Cancer Res2001，7，12：	1
6	Phase I and pharmacokinetic study of bortezomib in combination with idarubiein and eytarabine in patients with acute myelogenous leukemia显示文摘	Attar EC De Angelo DJ Supko JG	2008	Clin Cancer Res2008，14，5：	1
7	Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphohlastic leukemia显示文摘	Silverman LB Supko JG Stevenson KE	2010	Blood2010，115，7：	1
8	A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lympho- mas显示文摘	HONG D S KURZROCK R SUPKO J G	2012	Clin Cancer Res2012，18，12：	1
9	Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily显示文摘	Eder JP Supko JG Clark JW	2002	J Clin Oncol2002，20，18：	1
10	A Phase I study of bortezomib plus irinotecan in patients with advanced solid tumors显示文摘	Ryan D P O'Neil B H Supko J G	2006	Cancer2006，107，11：	1
11	Phase I Clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily显示文摘	Eder JPJr Supko JG Clark JW	2002	J Clin Oncol2002，20，18：	1
12	Ecteinascidin-743(ET-743)for chemotherapy-naive patients with advanced soft tissue sarcomas:multicenter phase II and pharmacokinetic study显示文摘	Garcia-Carbonero R Supko JG Maki RG		0，，：	1
13	Pharmacokinetics of irinotecan and the proteasome inhibitor bortezomib in adult patients with solid malignancies 显示文摘	Supko JG Eder JP Lynch TJ	2003	Proc Am Soc Clin Oncol2003，22，1：	1
14	Phase Ⅱ and pharmaeokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy显示文摘	Garcia-Carbonero R Supko JG Manola J	2004	J Clin Oncol2004，22，8：	1
15	Phase I clinical trail of recombinant human endostatin administered as a short intravennous infusion repeated daily 显示文摘	Eder JP Supko JG Clark JW	2002	J Clin Oncol2002，20，18：	1
16	Current perspectives on the clinical experience, pharmacology, and continued devel- opment of the camptothecins显示文摘	Garcia-Carbonero R Supko JG	2002	Clin Cancer Res2002，8，3：	1
17	Intravenous PEG- asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastie leukemia 显示文摘	Silverman LB Supko JG Stevenson KE	2010	Blood2010，115，7：	1
18	Phasc I clinical trial of recombinant human endostatin administered as a short intrave- nous infusion repeated daily显示文摘	Eder JPJr Supko JG CIark JW	2002	Clin Oncol2002，20，18：	1
19	Phase I clinical trial of recombinant human endostratin adminsistered as a short intravenousinfusion repeated daily 显示文摘	Eder JP Supko JG Clark JW	2003	J Clin Oncol2003，20，18：	1
20	A phase Ⅱ and pharmacokinetic study of ecteinascidin 743 in patients with gastrointestinal stromal tumors 显示文摘	Ryan DP Puchalski T Supko JG	2002	Oncologist2002，7，6：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示